CAR-T: A New Twist on Transplants for Cancer Patients

Learn how our own immune system cells can be engineered to fight some cancers. 

October 3, 2017

Dr. Krishna Komanduri who is Professor of Medicine, Microbiology & Immunology and is the Director of the Adult Stem Cell Transplant Program and Associate Director for Clinical Innovation at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine dicusses:

  • cellular therapies that are important and emerging for blood cancer patients
  • perspectives on the evolution of allogeneic hematopoietic transplantation
  • basics of T-cell biology
  • the science of emerging T cell immunotherapies, including CAR-T
  • engineering T-cells to fight cancer
  • side effects of CAR-T therapy
  • concerns about access to treatment
  • limitations of CAR-T and other immunotherapies

This video is 50 minutes followed by a 25 minute Q & A session;

This article is in these categories: This article is tagged with: